During the last session, Rocket Pharmaceuticals Inc (NASDAQ:RCKT)’s traded shares were 0.88 million, with the beta value of the company hitting 1.11. At the end of the trading day, the stock’s price was $21.98, reflecting an intraday loss of -0.54% or -$0.12. The 52-week high for the RCKT share is $32.53, that puts it down -48.0 from that peak though still a striking 32.26% gain since the share price plummeted to a 52-week low of $14.89. The company’s market capitalization is $1.99B, and the average trade volume was 721.47K shares over the past three months.
Rocket Pharmaceuticals Inc (NASDAQ:RCKT) trade information
Rocket Pharmaceuticals Inc (RCKT) registered a -0.54% downside in the last session and has traded in the red over the past 5 sessions. The stock plummet -0.54% in intraday trading to $21.98, hitting a weekly high. The stock’s 5-day price performance is -3.60%, and it has moved by -19.34% in 30 days. Based on these gigs, the overall price performance for the year is 25.39%.
Rocket Pharmaceuticals Inc (RCKT) estimates and forecasts
Statistics show that Rocket Pharmaceuticals Inc has underperformed its competitors in share price, compared to the industry in which it operates. Rocket Pharmaceuticals Inc (RCKT) shares have gone up 21.98% during the last six months, with a year-to-date growth rate less than the industry average at -0.68% against 12.90.
Meanwhile, a consensus of 9 analyst(s) estimates revenue growth to 110k by the end of current fiscal year.
An analysis of the company’s performance over the past 5 years shows that the company’s earnings shrunk an estimated -9.09%. While earnings are projected to return 10.22% in 2024, the next five years will return 41.70% per annum.
RCKT Dividends
Rocket Pharmaceuticals Inc is due to release its next quarterly earnings in May. However, it is important to remember that the dividend yield ratio is merely an indicator meant to only serve as guidance.
